Menu
Medical Procedure
General Care Delivery
General Care Delivery Day Surgery / Outpatient

Kidney Function Tests (e.g., Serum Creatinine, eGFR)

Protocol / Details

Kidney function assessment is performed via venipuncture to collect a blood sample. The procedure involves verifying patient identity, cleansing the antecubital fossa with 70% isopropyl alcohol, performing a standard venous draw using a sterile needle and evacuated tube system, and applying pressure to the site to ensure hemostasis. The sample is processed for Serum Creatinine measurement, which is then used to calculate the Estimated Glomerular Filtration Rate (eGFR) using the CKD-EPI formula to evaluate renal clearance and metabolic function.

Procedure Type
Other Procedure
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Patient should be fasting for 8-12 hours if required by specific laboratory guidelines. Ensure proper hydration status is documented. Verify patient identification and obtain verbal consent.

Apply a sterile adhesive bandage to the puncture site. Instruct the patient to keep the site clean and dry for 24 hours. The patient is discharged immediately with follow-up instructions provided for result review.

Comprehensive Clinical Guide: Kidney Function Tests (Serum Creatinine and eGFR)

1. Introduction and Overview

Kidney function tests represent the cornerstone of diagnostic nephrology and general internal medicine. Because the kidneys serve as the primary filtration system for metabolic waste, fluid balance, and electrolyte homeostasis, their functional integrity is a vital indicator of systemic health. Among the battery of available tests, Serum Creatinine (SCr) and the Estimated Glomerular Filtration Rate (eGFR) are the gold standards for assessing renal clearance capacity.

In an orthopedic and surgical context, these tests are non-negotiable. Before any major procedure involving anesthesia, contrast media, or nephrotoxic medications, a patient’s renal profile must be established to prevent acute kidney injury (AKI) and ensure appropriate dosing of post-operative analgesics and anticoagulants.


2. Deep-Dive: Technical Specifications and Mechanisms

Serum Creatinine (SCr)

Creatinine is a chemical waste product generated by the metabolism of muscle tissue (creatine phosphate). Under normal physiological conditions, the kidneys filter creatinine from the blood and excrete it in urine.
* Mechanism: Creatinine is produced at a relatively constant rate depending on an individual’s muscle mass. Because it is filtered by the glomeruli and minimally secreted by the tubules, its concentration in the blood is inversely proportional to the Glomerular Filtration Rate (GFR).
* Limitations: SCr levels can be influenced by non-renal factors, including extreme dietary protein intake, heavy exercise, muscle atrophy, and certain medications (e.g., cimetidine or trimethoprim).

Estimated Glomerular Filtration Rate (eGFR)

The eGFR is a mathematical calculation that provides a more accurate assessment of kidney function than creatinine alone. It adjusts the SCr value for variables such as age, sex, race, and body surface area.
* The CKD-EPI Formula: The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is currently the clinical standard. It is preferred over the older MDRD (Modification of Diet in Renal Disease) study equation, particularly in patients with higher GFR values.
* Clinical Significance: eGFR allows clinicians to stage Chronic Kidney Disease (CKD) according to the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines.

Stage GFR (mL/min/1.73m²) Clinical Status
G1 ≥ 90 Normal or high function
G2 60–89 Mildly decreased
G3a 45–59 Mildly to moderately decreased
G3b 30–44 Moderately to severely decreased
G4 15–29 Severely decreased
G5 < 15 Kidney failure (ESRD)

3. Clinical Indications and Usage

Pre-Operative Screening

In orthopedic surgery, patients are frequently exposed to NSAIDs (non-steroidal anti-inflammatory drugs) and prophylactic antibiotics (e.g., vancomycin), both of which can be nephrotoxic. Pre-operative testing is essential to:
* Baseline Establishment: Creating a reference point for post-operative monitoring.
* Dosing Adjustments: Tailoring anesthesia protocols for patients with compromised renal clearance.
* Contrast Avoidance: Determining if a patient can safely undergo imaging with iodinated contrast media.

Chronic Disease Management

  • Hypertension/Diabetes: Patients with these comorbidities require routine monitoring (every 3–6 months) to track the progression of nephropathy.
  • Medication Monitoring: Patients on ACE inhibitors, ARBs, or lithium require serial blood work to ensure therapeutic levels are not causing renal stress.

Symptomatic Evaluation

Clinicians order these tests when patients present with:
* Unexplained edema (swelling in limbs).
* Changes in urination frequency or color (hematuria).
* Persistent hypertension.
* Signs of uremia (fatigue, nausea, metallic taste).


4. Patient Preparation and Procedure

Pre-Test Preparation

To ensure the accuracy of these tests, patients should be instructed on the following:
1. Hydration: Maintain normal fluid intake unless otherwise specified.
2. Dietary Restrictions: Avoid excessive consumption of cooked meat (which contains creatine) for 24 hours prior to the test.
3. Physical Activity: Avoid strenuous exercise 48 hours prior, as it can cause a transient spike in serum creatinine.
4. Medication Review: Inform the clinician of all current medications, particularly diuretics, NSAIDs, and supplements.

The Procedure

The collection process is a routine venipuncture:
* Specimen Collection: A phlebotomist draws blood into a serum-separator tube (SST).
* Laboratory Analysis: The sample is processed using enzymatic methods for creatinine measurement, followed by the automated calculation of the eGFR.
* Turnaround Time: Results are typically available within 24 hours, though point-of-care (POC) devices can provide rapid results in acute settings.


5. Risks, Side Effects, and Contraindications

While the blood test itself carries negligible risk (standard venipuncture complications like bruising or lightheadedness), the interpretation of the results carries clinical risks:
* False Reassurance: Normal creatinine levels in an elderly patient with low muscle mass can mask significant renal impairment (due to the "creatinine gap").
* Delayed Diagnosis: Relying solely on SCr without calculating eGFR leads to under-diagnosis of early-stage kidney disease.
* Contrast-Induced Nephropathy (CIN): In patients with a baseline eGFR < 30, the use of contrast media for imaging poses a high risk of acute kidney injury.


6. Post-Procedure and Outcomes

Following the test, results are categorized. If findings are abnormal, the following protocols are typically initiated:
* Serial Monitoring: Repeating the test in 2–4 weeks to determine if the dysfunction is acute or chronic.
* Urinalysis: Assessing for proteinuria or albuminuria, which often precedes a drop in eGFR.
* Renal Ultrasound: Imaging the kidneys to rule out obstructive uropathy (e.g., kidney stones or masses).
* Specialist Referral: Consultation with a nephrologist for any patient with GFR < 30 or rapid decline in function.


7. Frequently Asked Questions (FAQ)

1. Why is my creatinine normal but my eGFR low?
This often occurs in patients with lower muscle mass (e.g., the elderly or those with chronic illness). Because creatinine production is lower, the blood level appears "normal," but the kidney’s ability to filter the blood is actually impaired.

2. Can I eat before a kidney function test?
Yes, but avoid high-protein meals or heavy meat consumption the day before, as these can artificially inflate creatinine levels.

3. What does it mean if my eGFR is 55?
An eGFR of 55 indicates Stage 3a Chronic Kidney Disease. This suggests a mild-to-moderate decrease in function. It requires medical follow-up to identify the cause and prevent further decline.

4. How often should I have my kidneys checked?
Healthy individuals without risk factors usually do not require routine screening. However, those with diabetes, hypertension, or a family history of kidney disease should be screened annually.

5. Do NSAIDs (like Ibuprofen) affect these tests?
Yes. NSAIDs reduce blood flow to the kidneys. Chronic use can lead to a decrease in eGFR and potential long-term kidney damage.

6. Is a kidney function test the same as a urinalysis?
No. A kidney function test (blood) measures the filtration rate, while a urinalysis checks for protein, blood, or infection in the urine. They are often used together for a complete picture.

7. Can dehydration affect my results?
Absolutely. Dehydration causes a temporary decrease in blood flow to the kidneys, which can cause a transient spike in creatinine and a falsely low eGFR.

8. What is the difference between AKI and CKD?
AKI (Acute Kidney Injury) is a sudden, often reversible drop in function. CKD (Chronic Kidney Disease) is a permanent loss of function over a period of 3 months or more.

9. Are there any natural ways to improve eGFR?
Management of underlying conditions like blood pressure and blood sugar is the most effective way to preserve kidney function. Staying well-hydrated and reducing salt intake are also vital.

10. Do I need to stop my blood pressure medication before the test?
Generally, no. Always take your medications as prescribed unless your doctor explicitly tells you to skip a dose before blood work.


8. Alternative Treatments and Diagnostic Measures

When SCr and eGFR are insufficient for a full clinical picture, physicians may employ:
* Cystatin C: A more sensitive marker for GFR that is less affected by muscle mass, age, or diet. It is often used as a "tie-breaker" when creatinine results are ambiguous.
* 24-Hour Urine Collection: Measuring the actual clearance of creatinine over a full day. This is the "gold standard" for accuracy but is cumbersome and rarely used in routine practice.
* Renal Biopsy: Reserved for cases where the cause of renal decline is unknown and requires histological examination.

Conclusion

Serum Creatinine and eGFR remain the indispensable pillars of renal assessment. For the orthopedic specialist, understanding these metrics is not merely a bureaucratic requirement—it is a patient safety imperative. By systematically monitoring renal clearance, clinicians can mitigate the risks of surgical complications, ensure the safe administration of medications, and provide the proactive care necessary to preserve long-term health.

Share this procedure: